SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424,814 | -51.5% | 59,681 | -30.6% | 0.00% | -50.0% |
| Q2 2023 | $876,216 | +155.6% | 86,000 | +127.5% | 0.00% | +100.0% |
| Q1 2023 | $342,841 | +1082.2% | 37,809 | +847.6% | 0.00% | – |
| Q4 2022 | $29,000 | -9.4% | 3,990 | -19.0% | 0.00% | – |
| Q3 2022 | $32,000 | +146.2% | 4,926 | +85.0% | 0.00% | – |
| Q2 2022 | $13,000 | -38.1% | 2,663 | -26.8% | 0.00% | – |
| Q1 2022 | $21,000 | +5.0% | 3,637 | -6.9% | 0.00% | – |
| Q4 2021 | $20,000 | -20.0% | 3,907 | +1.3% | 0.00% | – |
| Q3 2021 | $25,000 | +1150.0% | 3,857 | +980.4% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 357 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,207,009 | $15,713,904 | 7.44% |
| 5AM Venture Management, LLC | 1,200,647 | $8,548,607 | 2.46% |
| Worth Venture Partners, LLC | 539,665 | $3,842,415 | 2.28% |
| COWEN AND COMPANY, LLC | 1,795,647 | $12,785,006 | 0.90% |
| Orbimed Advisors | 5,559,528 | $39,583,839 | 0.84% |
| Rubric Capital Management LP | 2,713,287 | $19,318,603 | 0.72% |
| AlphaCentric Advisors LLC | 125,000 | $890,000 | 0.50% |
| RTW INVESTMENTS, LP | 3,297,843 | $23,480,642 | 0.50% |
| Tejara Capital Ltd | 101,414 | $722,068 | 0.41% |
| Leucadia National | 745,550 | $5,308,316 | 0.05% |